Abstract

The pharmacokinetics of carbon 14-labeled lycopene will be evaluated in dogs after single, intravenous administration. Dose administration with unlabeled compound will continue for 1 month after which another pharmacokinetic evaluation by intravenous administration will be evaluated. In addition, principle metabolites of the parent compound and the tissue distribution will be evaluated.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN085064-003
Application #
6358816
Study Section
Project Start
1998-09-30
Project End
2001-05-29
Budget Start
2000-09-30
Budget End
2001-05-29
Support Year
Fiscal Year
2000
Total Cost
$22,674
Indirect Cost

  Institution

Name
University of Illinois at Chicago
Department
Type
Organized Research Units
DUNS #
121911077
City
Chicago
State
IL
Country
United States
Zip Code
60612